Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 8, keine Gesamtzahl für „controlled“
Suchtreffer
Begriffe & Kennungen
Conexxence · 4.8 · In a pooled analysis of data from all phase II and phase III placebo-controlled studies, influenza-like illnes
Eintrag öffnenConexxence · 4.8 · Skin infections In phase III placebo-controlled clinical trials, the overall incidence of skin infections was
Eintrag öffnenConstella · 4.8 · Summary of the safety profile Linaclotide has been given orally to 1 166 patients with IBS-C in controlled cli
Eintrag öffnenCopalia HCT · 4.8 · In the 8-week controlled clinical study, changes in laboratory parameters observed with the combination of Cop
Eintrag öffnenCopalia HCT · 4.8 · In the 8-week controlled clinical study, no significant new or unexpected adverse reactions were observed with
Eintrag öffnenCopalia HCT · 4.8 · The safety of Copalia HCT has been evaluated at its maximum dose of 10 mg/320 mg/25 mg in one controlled short
Eintrag öffnenCopalia · 4.8 · The safety of Copalia has been evaluated in five controlled clinical studies with 5,175 patients, 2,613 of who
Eintrag öffnenCresemba · 4.8 · In a double-blind, randomized, active-controlled clinical study of 516 patients with invasive fungal disease c
Eintrag öffnenCresemba · 4.8 · In a double-blind, randomized, active-controlled clinical study of 516 patients with invasive fungal disease c
Eintrag öffnenCrysvita · 4.8 · Hyperphosphataemia Adult patients with XLH or TIO: In XLH patients, in the placebo-controlled treatment period
Eintrag öffnenCrysvita · 4.8 · Restless legs syndrome Adult patients with XLH or TIO: In XLH patients, in the placebo-controlled treatment pe
Eintrag öffnenCymbalta · 4.3 · The initiation of treatment with Cymbalta is contraindicated in patients with uncontrolled hypertension that c
Eintrag öffnenCyramza · 4.8 · Tables 6 and 7 below list the adverse drug reactions (ADRs) from placebo controlled phase III clinical trials
Eintrag öffnenDafiro HCT · 4.8 · In the 8-week controlled clinical study, changes in laboratory parameters observed with the combination of Daf
Eintrag öffnenDafiro HCT · 4.8 · In the 8-week controlled clinical study, no significant new or unexpected adverse reactions were observed with
Eintrag öffnenDafiro HCT · 4.8 · The safety of Dafiro HCT has been evaluated at its maximum dose of 10 mg/320 mg/25 mg in one controlled short-
Eintrag öffnenDafiro · 4.8 · The safety of Dafiro has been evaluated in five controlled clinical studies with 5,175 patients, 2,613 of whom
Eintrag öffnenDegevma · 4.8 · 9 New primary malignancy In the primary double blind treatment phases of four phase III active-controlled clin
Eintrag öffnenDegevma · 4.8 · In the primary treatment phases of three phase III active-controlled clinical trials in patients with advanced
Eintrag öffnenDegevma · 4.8 · In three phase III active-controlled clinical trials in patients with advanced malignancies involving bone, hy
Eintrag öffnen